- Home
- CRESY vs RLAY Comparison
CRESY vs RLAY Comparison
Compare CRESY & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRESY
- RLAY
- Stock Information
- Founded
- CRESY 1936
- RLAY 2015
- Country
- CRESY Argentina
- RLAY United States
- Employees
- CRESY N/A
- RLAY N/A
- Industry
- CRESY Real Estate
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRESY Finance
- RLAY Health Care
- Exchange
- CRESY Nasdaq
- RLAY Nasdaq
- Market Cap
- CRESY 615.0M
- RLAY 619.0M
- IPO Year
- CRESY 1997
- RLAY 2020
- Fundamental
- Price
- CRESY $9.14
- RLAY $4.09
- Analyst Decision
- CRESY
- RLAY Strong Buy
- Analyst Count
- CRESY 0
- RLAY 13
- Target Price
- CRESY N/A
- RLAY $18.00
- AVG Volume (30 Days)
- CRESY 343.5K
- RLAY 1.2M
- Earning Date
- CRESY 11-07-2025
- RLAY 11-05-2025
- Dividend Yield
- CRESY 6.44%
- RLAY N/A
- EPS Growth
- CRESY N/A
- RLAY N/A
- EPS
- CRESY 0.12
- RLAY N/A
- Revenue
- CRESY $767,102,963.00
- RLAY $8,355,000.00
- Revenue This Year
- CRESY N/A
- RLAY $31.55
- Revenue Next Year
- CRESY N/A
- RLAY N/A
- P/E Ratio
- CRESY $6.69
- RLAY N/A
- Revenue Growth
- CRESY N/A
- RLAY N/A
- 52 Week Low
- CRESY $8.39
- RLAY $1.78
- 52 Week High
- CRESY $14.23
- RLAY $8.19
- Technical
- Relative Strength Index (RSI)
- CRESY 40.12
- RLAY 60.92
- Support Level
- CRESY $8.41
- RLAY $3.89
- Resistance Level
- CRESY $9.15
- RLAY $4.34
- Average True Range (ATR)
- CRESY 0.46
- RLAY 0.24
- MACD
- CRESY -0.05
- RLAY 0.02
- Stochastic Oscillator
- CRESY 35.21
- RLAY 69.94
About CRESY Cresud S.A.C.I.F. y A.
Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).